Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05265169 · ClinicalTrials.gov registry record · NA
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
A NA study of Colorectal Liver Metastases, sponsored by Society of Interventional Oncology.
- Recruiting
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 7
- Study locations
NCT05265169: Recruiting NA study of Colorectal Liver Metastases, sponsored by Society of Interventional Oncology.
NCT05265169 is a NA study of Colorectal Liver Metastases that is actively recruiting participants, run by Society of Interventional Oncology. The registered enrollment target is 275 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05265169, a NA study of Colorectal Liver Metastases, is actively recruiting participants, sponsored by Society of Interventional Oncology.
- RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 7
- Study locations
Study Summary
To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.
Primary Outcome
See Above
Conditions Studied
Interventions
- DEVICE Microwave ablation
Study Locations (7)
Other
- National and Kapodistrian University of Athens (NKUA) - Athens
- Amsterdam UMC - Amsterdam
Florida
- Miami Cancer Institute - Miami
Minnesota
- Mayo Clinic - Rochester
New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- MD Anderson Cancer Center - Houston
Wisconsin
- Medical College of WI - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2023-01-13 |
| Est. Completion | 2027-12-10 |
| Phase | NA |
What NCT05265169 shows while recruiting
NCT05265169 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Colorectal Liver Metastases appearing as the primary indexed condition, and to 1 intervention - of which Microwave ablation is the first listed.
NCT05265169 lists 7 locations in 6 states (Other, Florida, Minnesota).
Frequently Asked Questions
What is clinical trial NCT05265169 about?
NCT05265169 is a clinical study titled "Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)". To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.
What is the current status of trial NCT05265169?
This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2023-01-13. Estimated completion is 2027-12-10.
What conditions does trial NCT05265169 study?
This clinical trial studies the following conditions: Colorectal Liver Metastases.
What interventions are being tested in trial NCT05265169?
The interventions under investigation include: Microwave ablation (DEVICE).
Who is sponsoring clinical trial NCT05265169?
This trial is sponsored by Society of Interventional Oncology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05265169 being conducted?
This trial has 7 study locations across Florida, Minnesota, New York, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Liver Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05265169's enrollment target sits among peer trials
275 383rd of 2000 higher than 1,616 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI